Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham R Robertson

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Pharmacogenomics|February 28, 2003
Predicting inductive drug-drug interactionsChristopher Liddle, Graham R Robertson
Seminars in Cell & Developmental Biology|November 4, 2015
Lipolytic and thermogenic depletion of adipose tissue in cancer cachexiaMaria Tsoli, Michael M Swarbrick, Graham R Robertson
Biomarkers in Medicine|June 27, 2012
HNF4α: a new biomarker in colon cancer?Karthikeyani Chellappa, Graham R Robertson, Frances M Sladek
Expert Opinion on Drug Metabolism & Toxicology|February 6, 2008
Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosingMarina Kacevska, Graham R Robertson, Stephen J Clarke, et al.
Hepatology (Baltimore, Md.)|March 1, 2002
Liver regeneration in obese mice with fatty livers: does the impairment have relevance for other types of fatty liver disease?Geoffrey C Farrell, Graham R Robertson, Isabelle Leclercq, et al.
Journal of Hepatology|July 20, 2002
Leptin is essential for the hepatic fibrogenic response to chronic liver injuryIsabelle A Leclercq, Geoffrey C Farrell, Rixt Schriemer, et al.
Nutrients|May 23, 2018
Vitamin D in Vascular Calcification: A Double-Edged Sword?Jeffrey Wang, Jimmy J Zhou, Graham R Robertson, et al.
Molecular Pharmacology|July 20, 2002
Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptorBryan Goodwin, Ecushla Hodgson, Daniel J D'Costa, et al.
The International Journal of Biochemistry & Cell Biology|December 26, 2006
Pregnane X receptor: promiscuous regulator of detoxification pathwaysMarko Matic, Andre Mahns, Maria Tsoli, et al.
Pharmaceutical Research|April 23, 2013
Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signallingMarina Kacevska, Andre Mahns, Rohini Sharma, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Pharmacogenomics|February 28, 2003
Predicting inductive drug-drug interactionsChristopher Liddle, Graham R Robertson
Seminars in Cell & Developmental Biology|November 4, 2015
Lipolytic and thermogenic depletion of adipose tissue in cancer cachexiaMaria Tsoli, Michael M Swarbrick, Graham R Robertson
Biomarkers in Medicine|June 27, 2012
HNF4α: a new biomarker in colon cancer?Karthikeyani Chellappa, Graham R Robertson, Frances M Sladek
Expert Opinion on Drug Metabolism & Toxicology|February 6, 2008
Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosingMarina Kacevska, Graham R Robertson, Stephen J Clarke, et al.
Hepatology (Baltimore, Md.)|March 1, 2002
Liver regeneration in obese mice with fatty livers: does the impairment have relevance for other types of fatty liver disease?Geoffrey C Farrell, Graham R Robertson, Isabelle Leclercq, et al.
Journal of Hepatology|July 20, 2002
Leptin is essential for the hepatic fibrogenic response to chronic liver injuryIsabelle A Leclercq, Geoffrey C Farrell, Rixt Schriemer, et al.
Nutrients|May 23, 2018
Vitamin D in Vascular Calcification: A Double-Edged Sword?Jeffrey Wang, Jimmy J Zhou, Graham R Robertson, et al.
Molecular Pharmacology|July 20, 2002
Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptorBryan Goodwin, Ecushla Hodgson, Daniel J D'Costa, et al.
The International Journal of Biochemistry & Cell Biology|December 26, 2006
Pregnane X receptor: promiscuous regulator of detoxification pathwaysMarko Matic, Andre Mahns, Maria Tsoli, et al.
Pharmaceutical Research|April 23, 2013
Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signallingMarina Kacevska, Andre Mahns, Rohini Sharma, et al.
Pageof 3